Hirawat Samit
SEC CIK 1781290 · EDGAR
BoughtSold
Most active insiders at PCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cross Shawn | CFO | — | $1.52M |
| 2 | WILLIAMS KRISTEN | Chief Administrative Off | — | $498.2K |
| 3 | RIKER LAUREN | SVP, Fin | — | $261.3K |
| 4 | SLONIN JONATHAN | Chief Medical Off | — | $240.4K |
| 5 | Froimson Mark | Dir | — | $10.9K |
| 6 | BIGAL MARCELO | Dir | — | — |
| 7 | Young Alethia | Dir | — | — |
| 8 | Teehan Brendan | Chief Commercial Off | — | — |
| 9 | Lee Frank D. | CEO, Dir | — | — |
| 10 | CHRISTIE CHRISTOPHER | Dir | — | — |
| 11 | Hirawat Samit | Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 21:07 | 2026-06-10 | PCRX | Pacira BioSciences, Inc. | Hirawat Samit | Dir | A - Grant | $0.00 | +6,405 | 6,405 | New | $0 |
| 2025-04-29 | 2025-04-25 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | P - Purchase | $47.58 | +4,250 | 83.5K | +5% | +$202.2K | |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | J - Other | $0.00 | -12.7K | 88.5K | -13% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $63.11 | -16.1K | 79.3K | -17% | -$1.01M |
| DM | 2025-03-12 | 2025-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +44.1K | 73.9K | +148% | $0 |
| 2025-02-19 | 2025-02-14 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | P - Purchase | $54.84 | +1,823 | 63.9K | +3% | +$100.0K | |
| 2024-11-05 | 2024-11-01 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | P - Purchase | $54.68 | +1,830 | 62.1K | +3% | +$100.1K | |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | J - Other | $0.00 | -11.7K | 50.8K | -19% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $53.79 | -13.6K | 49.0K | -22% | -$734.2K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +38.4K | 53.9K | +248% | $0 |
| D | 2023-07-05 | 2023-07-01 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +9,357 | 52.0K | +22% | $0 |
| D | 2023-07-05 | 2023-07-01 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $63.95 | -4,787 | 47.2K | -9% | -$306.1K |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $65.71 | -22.4K | 28.9K | -44% | -$1.47M |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +39.0K | 25.5K | New | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | J - Other | $0.00 | +4,800 | 29.4K | +20% | $0 |
| D | 2022-07-05 | 2022-07-01 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +9,356 | 26.1K | +56% | $0 |
| D | 2022-07-05 | 2022-07-01 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $76.84 | -4,786 | 21.3K | -18% | -$367.8K |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $68.42 | -5,205 | 14.1K | -27% | -$356.1K |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | J - Other | $0.00 | +1,101 | 16.5K | +7% | $0 |
| DM | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +9,074 | 15.9K | +132% | $0 |
| D | 2021-07-06 | 2021-07-01 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $66.56 | -4,786 | 11.8K | -29% | -$318.6K |
| D | 2021-07-06 | 2021-07-01 | BMY | Bristol Myers Squibb | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +9,356 | 16.5K | +130% | $0 |
Purchase Sale Sale after option exercise All abbreviations